Preview

Современная ревматология

Расширенный поиск

Рекомендации по ведению больных анкилозирующим спондилитом.По материалам Международной рабочей группы по изучению анкилозирующего спондилита(ASAS - Assesment Ankylosing Spondylitis Work Group)

https://doi.org/10.14412/1996-7012-2009-566

Полный текст:

Об авторе

А. Г. Бочкова



Литература

1. <div><p>Braun J., Bollow M., Remlinger G. et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.</p><p>Rudwaleit M., Landewe R., van der Heijde D. et al. SpondyloArthritis international Society (ASAS) Classification Criteria for Axial Spondylarthritis (Part II): Validation and Final Selection. Ann Rheum Dis published online 17 Mar 2009.</p><p>Zochling J., van der Heijde D., Burgos-Vargas R. et al. 'ASsessment in AS' International Working Group European League Against Rheumatism (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.</p><p>Kiltz U., van der Heijde D., Mielants H. et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis 2009 Sep;68(9):1381-6.</p><p>Garrett S., Jenkinson T., Kennedy Lg. et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Activity Index. J Rheumatol 1994;21:2286-91.</p><p>Calin A., Garrett S., Whitelock H. et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index. J Rheumatol 1994;21:2281-85.</p><p>Maksymowych W.P., Mallon C., Morrow S. et al. Development and validation of the spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009;68:948-53.</p><p>Heuft-Dorenbosch L., Spoorenberg A., van Tubergen A. et al. Assessment of enthesi-tis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-32.</p><p>Van Tubergen A., Landewe R., van der Heijde D. et al. Combined Spa-Exercise Therapy Is Effective in Patients With Ankylosing Spondylitis: A Randomized Controlled Trial. Arthritis Care &amp; Research 2001;45:430-38.</p><p>Dagfinrud H., Kvien T.K., Hagen K.B. The Cochrane review of physiotherapy interventions for ankylosing spondylitis. J Rheumatol 2005;32:10;1899-906.</p><p>Song I.H., Poddubnyy D.A., Rudwaleit M. et al. Benefits and risks of ankylosing spondylitis treatment with nonsteroidal anti-inflammatory drugs. Arthritis Rheum 2008;58:929-38.</p><p>Wanders A., van der Heijde D., Landewe R. et al. Non-steroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthr &amp; Rheum 2005;52(6):1756-65.</p><p>Braun J., Bollow M., Seyrekbasan F. et al. Computed tomography guied corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and follow-up by dynamic MRI. J Rheumatol 1996;23:659-64.</p><p>Braun J., Alten R., Burmester G. et. al. Efficacy of sulfasalasine in undifferentiated spondyloarthritis and early ankylosing spondylitis - a multicenter randomized controlled trial. Ann Rheum Dis 2006;65:1147-53.</p><p>Haibel H., Rudwaleit M., Braun J. et al. Six months open label trial of leflunomide in active ankylosing spondylitis. Ann Rheum Dis 2005;64:296-8.</p><p>Haibel H., Brandt H.C., Song I.H. et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Arthritis Rheum 2006;54:678-81.</p><p>Van Denderen J.C., Van der Paardt M., Nurmohamed M.T. et al. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis. Ann Rheum Dis 2005;64(12):1761-4.</p><p>Van der Heijde D., Dijkmans B., Geusens P. et al. Efficacy and safety of infliximab in patients with ankylosing spondilitis. Results of a randomized, placebo controlled trial (ASSERT). Arthritis Rhum 2005;52:582-91.</p><p>Breban M., Vignon E., Claudepierre P. et al. Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) 2002;41:1280-5.</p><p>Davis J.C., van der Heijde D., Braun J. et al. Recombinant Human Tumor Necrosis Factor Receptor (Etanercept) for Treating Ankylosing Spondylitis. A Randomized, Controlled Trial. Arthr &amp; Rheum 2003;48:3230-6.</p><p>Van der Heijde D., Kivitz A., Schiff M.H. et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis. Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54,2136-46.</p><p>Haibel H., Rudwaleit M., Heldmann F. et al. Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis results of a 12-week randomized controlled trial. Arthritis Rheum 2008;58(7):1981-91.</p><p>Baraliakos X., Listing J., Brandt J. et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with tumor necrosis factor alpha receptor fusion protein etanercept. Artr Rheum 2005;52:1216-23.</p><p>Van der Heijde D., Landewe R.,Einstein S. et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment etanercept. Arthritis Rheum 2008;58:1324-31.</p><p>Van der Heijde D., Landewe R., Baraliakos X. et al. Ankylosing spondylitis study for the Evalution of Recombinant infliximab therapy study group. Radiographic findings 2 years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008;58:3063-70.</p></div><br />


Для цитирования:


Бочкова А.Г. Рекомендации по ведению больных анкилозирующим спондилитом.По материалам Международной рабочей группы по изучению анкилозирующего спондилита(ASAS - Assesment Ankylosing Spondylitis Work Group). Современная ревматология. 2009;3(4):5-10. https://doi.org/10.14412/1996-7012-2009-566

For citation:


Bochkova A.G. Rekomendatsii po vedeniyu bol'nykh ankiloziruyushchim spondilitom.Po materialam Mezhdunarodnoy rabochey gruppy po izucheniyu ankiloziruyushchego spondilita(ASAS - Assesment Ankylosing Spondylitis Work Group). Modern Rheumatology Journal. 2009;3(4):5-10. (In Russ.) https://doi.org/10.14412/1996-7012-2009-566

Просмотров: 1041


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)